Loading clinical trials...

Randomized Study of Letrozole and Trilostane for Medical Abortion | Clinical Trials | Clareo Health

TERMINATEDPhase 2NCT01615211

Randomized Study of Letrozole and Trilostane for Medical Abortion

In menstruation an effective shedding of the endometrial lining occurs. Both progesterone and estrogen levels fall sharply at this time. During medical abortion the endometrial shedding is sometimes i...

Lead sponsor: Kristina Gemzell Danielsson•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDNA

Second Trimester Medical Abortion

NCT04160221 · Medical Abortion, Complete or Unspecified, Without Complication

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 18, 2015Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment36

Start dateMay 2012

Last updatedMay 18, 2015

Locations shown

Karolinska University Hospital

Stockholm

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 18, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions